Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128369 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
A Phase 3 study, sponsored by Oculis.
- Terminated
- Registry status
- Phase 3
- Development phase
- 117
- Enrollment target
NCT06128369: Clinical Trial Phase 3 study, sponsored by Oculis.
NCT06128369 is a Phase 3 study that was terminated before completion, run by Oculis. The registered enrollment target is 117 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06128369, a Phase 3 study, was terminated before completion, sponsored by Oculis.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 117 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.
Interventions
- DRUG Dexamethasone Ophthalmic Suspension
- OTHER Vehicle of OCS-01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2024-05-09 |
| Phase | Phase 3 |
Why NCT06128369 stopped before completion
NCT06128369 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone Ophthalmic Suspension is the first listed.
NCT06128369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06128369 about?
NCT06128369 is a clinical study titled "Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery". The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.
What is the current status of trial NCT06128369?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 117 participants. The study started on 2023-12-18. Estimated completion is 2024-05-09.
What interventions are being tested in trial NCT06128369?
The interventions under investigation include: Dexamethasone Ophthalmic Suspension (DRUG), Vehicle of OCS-01 (OTHER).
Who is sponsoring clinical trial NCT06128369?
This trial is sponsored by Oculis, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06128369's enrollment target sits among peer trials
117 1642nd of 2000 higher than 358 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI